BF Biosciences Ratios and Metrics

Market cap in millions PKR. Fiscal year is July - June.

Millions PKR. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2019
Period Ending	Mar '26 Mar 9, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2020 - 2019
Market Capitalization	11,583	14,902	-	-	-	-	Upgrade
Enterprise Value	11,322	15,314	-	-	-	-	Upgrade
Last Close Price	131.13	168.70	-	-	-	-	Upgrade
PE Ratio	19.34	33.33	-	-	-	-	Upgrade
Forward PE	-	22.57	-	-	-	-	Upgrade
PS Ratio	1.41	2.55	-	-	-	-	Upgrade
PB Ratio	2.31	3.20	-	-	-	-	Upgrade
P/TBV Ratio	2.31	3.20	-	-	-	-	Upgrade
P/OCF Ratio	16.22	49.71	-	-	-	-	Upgrade
EV/Sales Ratio	1.38	2.62	-	-	-	-	Upgrade
EV/EBITDA Ratio	8.97	16.53	-	-	-	-	Upgrade
EV/EBIT Ratio	11.53	20.85	-	-	-	-	Upgrade
Debt / Equity Ratio	0.33	0.37	0.94	1.32	0.96	0.61	Upgrade
Debt / EBITDA Ratio	1.29	1.86	2.96	8.59	6.45	1.42	Upgrade
Debt / FCF Ratio	4.88	-	4.24	-	-	-	Upgrade
Net Debt / Equity Ratio	-0.05	0.05	0.80	1.11	0.02	-0.26	Upgrade
Net Debt / EBITDA Ratio	-0.21	0.23	2.54	7.26	0.13	-0.61	Upgrade
Net Debt / FCF Ratio	-0.78	-7.19	3.63	-1.02	-0.04	1.03	Upgrade
Asset Turnover	0.89	0.83	0.64	0.36	0.41	0.87	Upgrade
Inventory Turnover	2.35	2.70	2.44	2.16	2.79	3.24	Upgrade
Quick Ratio	0.77	1.07	0.40	0.39	2.47	3.16	Upgrade
Current Ratio	1.71	2.36	1.17	1.13	3.21	4.19	Upgrade
Return on Equity (ROE)	12.71%	12.74%	17.79%	7.85%	18.65%	54.07%	Upgrade
Return on Assets (ROA)	6.66%	6.55%	7.71%	3.33%	4.08%	18.59%	Upgrade
Return on Invested Capital (ROIC)	11.96%	9.94%	11.18%	6.58%	14.48%	84.28%	Upgrade
Return on Capital Employed (ROCE)	14.50%	11.20%	16.00%	6.30%	6.50%	23.80%	Upgrade
Earnings Yield	5.17%	3.00%	-	-	-	-	Upgrade
FCF Yield	2.88%	-0.20%	-	-	-	-	Upgrade
Buyback Yield / Dilution	-28.87%	-27.79%	-	-0.01%	-	-	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.